Cite
Deletion of MyD88 in T‐Cells Worsens Cardiac Pathology Through Enhanced T‐Cell Survival and Induction of Cardiac Fibrosis.
MLA
Bayer, Abraham L., et al. “Deletion of MyD88 in T‐Cells Worsens Cardiac Pathology Through Enhanced T‐Cell Survival and Induction of Cardiac Fibrosis.” FASEB Journal, vol. 36, May 2022, p. N.PAG. EBSCOhost, https://doi.org/10.1096/fasebj.2022.36.S1.R3436.
APA
Bayer, A. L., Smolgovsky, S., Ngwenyama, N., Aronovitz, M., Kaur, K., & Alcaide, P. (2022). Deletion of MyD88 in T‐Cells Worsens Cardiac Pathology Through Enhanced T‐Cell Survival and Induction of Cardiac Fibrosis. FASEB Journal, 36, N.PAG. https://doi.org/10.1096/fasebj.2022.36.S1.R3436
Chicago
Bayer, Abraham L., Sandra Smolgovsky, Njabulo Ngwenyama, Mark Aronovitz, Kuljeet Kaur, and Pilar Alcaide. 2022. “Deletion of MyD88 in T‐Cells Worsens Cardiac Pathology Through Enhanced T‐Cell Survival and Induction of Cardiac Fibrosis.” FASEB Journal 36 (May): N.PAG. doi:10.1096/fasebj.2022.36.S1.R3436.